BioSig's PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases | Region

Westport, CT, Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac

Related Keywords

United States ,Texas ,Arizona ,Phoenix ,Americans ,Zachary Koch ,Hicham El Masry ,Kansas City Heart Rhythm Institute ,Texas Cardiac Arrhythmia Institute In Austin ,Exchange Commission ,Biosig Technologies Inc ,Heart Rhythm Society ,Principal Advisor Of Product Development At Biosig ,Texas Cardiac Arrhythmia Institute ,Andrew Ballou Biosig Technologies Inc ,Nasdaq ,Sig Technologies ,Near Field Tracking ,Cardiac Electrophysiologist ,Mayo Clinic ,Principal Advisor ,Product Development ,Cleveland Clinic ,Heart Rhythm ,Cardiovascular Electrophysiology ,Kansas City Heart Rhythm ,Biosig Technologies ,Private Securities Litigation Reform Act ,Nasdaq Capital Market ,Quarterly Report ,Global Market ,Ballou Biosig Technologies ,Vice President ,Investor Relations ,Farms Westport ,Region ,